Correlation Between X4 Pharmaceuticals and Biomea Fusion

Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Biomea Fusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Biomea Fusion into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between X4 Pharmaceuticals and Biomea Fusion, you can compare the effects of market volatilities on X4 Pharmaceuticals and Biomea Fusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Biomea Fusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Biomea Fusion.

Diversification Opportunities for X4 Pharmaceuticals and Biomea Fusion

-0.37

Correlation Coefficient

X4 Pharmaceuticals  Biomea Fusion

Very good diversification

The 3 months correlation between XFOR and Biomea is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Biomea Fusion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomea Fusion and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Biomea Fusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomea Fusion has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Biomea Fusion go up and down completely randomly.

Pair Corralation between X4 Pharmaceuticals and Biomea Fusion

Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 1.78 times more return on investment than Biomea Fusion. However, X4 Pharmaceuticals is 1.78 times more volatile than Biomea Fusion. It trades about 0.04 of its potential returns per unit of risk. Biomea Fusion is currently generating about -0.17 per unit of risk. If you would invest  67.00  in X4 Pharmaceuticals on October 11, 2024 and sell it today you would lose (3.00) from holding X4 Pharmaceuticals or give up 4.48% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

X4 Pharmaceuticals  vs.  Biomea Fusion

X4 Pharmaceuticals

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in X4 Pharmaceuticals are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, X4 Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Biomea Fusion

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biomea Fusion has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with X4 Pharmaceuticals and Biomea Fusion

The main advantage of trading using opposite X4 Pharmaceuticals and Biomea Fusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Biomea Fusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomea Fusion will offset losses from the drop in Biomea Fusion's long position.

The idea behind X4 Pharmaceuticals and Biomea Fusion pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.